Bausch Health Cos Cost of Goods Sold 2010-2024 | BHC
Bausch Health Cos cost of goods sold from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
Bausch Health Cos Annual Cost of Goods Sold
(Millions of US $) |
| 2023 |
$2,559 |
| 2022 |
$2,364 |
| 2021 |
$2,394 |
| 2020 |
$2,249 |
| 2019 |
$2,350 |
| 2018 |
$2,351 |
| 2017 |
$2,548 |
| 2016 |
$2,611 |
| 2015 |
$2,585 |
| 2014 |
$2,236 |
| 2013 |
$1,905 |
| 2012 |
$970 |
| 2011 |
$696 |
| 2010 |
$406 |
| 2009 |
$218 |
Bausch Health Cos Quarterly Cost of Goods Sold
(Millions of US $) |
| 2024-06-30 |
$719 |
| 2024-03-31 |
$640 |
| 2023-12-31 |
$705 |
| 2023-09-30 |
$623 |
| 2023-06-30 |
$649 |
| 2023-03-31 |
$582 |
| 2022-12-31 |
$652 |
| 2022-09-30 |
$584 |
| 2022-06-30 |
$577 |
| 2022-03-31 |
$551 |
| 2021-12-31 |
$626 |
| 2021-09-30 |
$582 |
| 2021-06-30 |
$612 |
| 2021-03-31 |
$574 |
| 2020-12-31 |
$645 |
| 2020-09-30 |
$590 |
| 2020-06-30 |
$495 |
| 2020-03-31 |
$519 |
| 2019-12-31 |
$635 |
| 2019-09-30 |
$584 |
| 2019-06-30 |
$594 |
| 2019-03-31 |
$537 |
| 2018-12-31 |
$602 |
| 2018-09-30 |
$582 |
| 2018-06-30 |
$594 |
| 2018-03-31 |
$573 |
| 2017-12-31 |
$647 |
| 2017-09-30 |
$659 |
| 2017-06-30 |
$646 |
| 2017-03-31 |
$596 |
| 2016-12-31 |
$665 |
| 2016-09-30 |
$658 |
| 2016-06-30 |
$658 |
| 2016-03-31 |
$630 |
| 2015-12-31 |
$730 |
| 2015-09-30 |
$648 |
| 2015-06-30 |
$685 |
| 2015-03-31 |
$522 |
| 2014-12-31 |
$571 |
| 2014-09-30 |
$561 |
| 2014-06-30 |
$586 |
| 2014-03-31 |
$518 |
| 2013-12-31 |
$732 |
| 2013-09-30 |
$575 |
| 2013-06-30 |
$298 |
| 2013-03-31 |
$300 |
| 2012-12-31 |
$218 |
| 2012-09-30 |
$230 |
| 2012-06-30 |
$210 |
| 2012-03-31 |
$312 |
| 2011-12-31 |
$154 |
| 2011-09-30 |
$166 |
| 2011-06-30 |
$173 |
| 2011-03-31 |
$203 |
| 2010-12-31 |
$214 |
| 2010-09-30 |
$63 |
| 2010-06-30 |
$67 |
| 2010-03-31 |
$62 |
| 2009-12-31 |
$73 |
| 2009-09-30 |
$51 |
| 2009-06-30 |
$50 |
| 2009-03-31 |
$45 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$2.956B |
$8.757B |
|
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|
